Twist Bioscience Ownership | Who Owns Twist Bioscience?


OverviewForecastRevenueFinancialsChartTranscripts

Twist Bioscience Ownership Summary


Twist Bioscience is owned by 86.26% institutional investors, 1.53% insiders, and 12.21% retail investors. Ark investment management is the largest institutional shareholder, holding 12.38% of TWST shares. ARK Disruptive Innovation Full Composite is the top mutual fund, with 7.21% of its assets in Twist Bioscience shares.

TWST Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockTwist Bioscience86.26%1.53%12.21%
SectorHealthcare Stocks 232.01%10.74%-142.75%
IndustryDiagnostics & Research Stocks35.25%10.80%53.95%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Ark investment management7.56M12.38%$239.79M
Artisan partners limited partnership6.41M10.69%$180.40M
William blair investment management5.95M9.75%$188.87M
Blackrock funding, inc. /de5.89M9.65%$186.99M
Vanguard group5.78M9.46%$183.22M
Blackrock5.42M9.33%$267.28M
Edgepoint investment group4.08M6.80%$114.88M
State street3.09M5.15%$86.93M
Sumitomo mitsui trust1.90M3.12%$60.36M
Nikko asset management americas1.90M3.12%$60.26M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Tao capital management lp828.82K17.64%$23.32M
First light asset management1.19M3.17%$33.62M
Seaport global advisors15.95K2.81%$785.97K
Soleus capital management1.86M2.18%$59.06M
Ark investment management7.56M1.59%$239.79M
Edgepoint investment group4.08M0.86%$114.88M
Iq eq fund management (ireland)371.55K0.81%$11.79M
Nikko asset management americas1.90M0.70%$60.26M
Brandywine managers20.97K0.57%$590.10K
William blair investment management5.95M0.53%$188.87M

Top Buyers

HolderShares% AssetsChange
William blair investment management5.95M0.53%1.81M
Edgepoint investment group4.08M0.86%1.70M
Artisan partners limited partnership6.41M0.26%1.35M
Ark investment management7.56M1.59%832.69K
State street3.09M0.00%588.07K

Top Sellers

HolderShares% AssetsChange
Point72 asset management530.03K0.03%-1.63M
Jpmorgan chase215.15K0.00%-803.09K
Morgan stanley866.36K0.00%-625.75K
Invesco1.80M0.01%-552.79K
Exoduspoint capital management, lp---471.83K

New Positions

HolderShares% AssetsChangeValue
Norges bank163.21K0.00%163.21K$7.58M
Cubist systematic strategies87.52K0.01%87.52K$2.46M
Affinity asset advisors45.00K0.26%45.00K$2.22M
Maxi investments cy35.00K0.20%35.00K$1.11M
Tudor investment corp et al25.46K0.00%25.46K$716.59K

Sold Out

HolderChange
Tfc financial management-1.00
Jfs wealth advisors-1.00
Twin peaks wealth advisors-2.00
Financial gravity asset management-2.00
Corecap advisors-7.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2025175-27.08%52,689,047-28.59%860.57%89-33.58%49-20.97%
Sep 30, 2025228-4.20%73,141,5369.76%1210.99%12714.41%59-32.18%
Jun 30, 2025242-8.33%69,840,7412.16%1160.89%112-17.65%867.50%
Mar 31, 20252643.53%69,120,8934.14%1150.92%1368.80%81-1.22%
Dec 31, 2024163-34.01%51,992,058-21.11%880.69%86-30.08%41-46.75%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
ARK Disruptive Innovation Full Composite4.42M7.21%567.04K
ARK Innovation ETF3.77M6.15%57.24K
ARK Genomic Revolution2.14M3.50%139.36K
ARK Genomic Revolution ETF2.07M3.38%-
State Street® SPDR® S&P® Biotech ETF1.97M3.21%-10.54K
Vanguard Total Stock Mkt Idx Inv1.83M2.99%5.82K
Vanguard US Total Market Shares ETF1.74M2.92%1.75K
iShares Russell 2000 ETF1.44M2.35%222.75K
Vanguard Small Cap Index1.32M2.15%-224.00
EdgePoint Global Portfolio Series F1.31M2.14%667.29K

Recent Insider Transactions


DateNameRoleActivityValue
Mar 06, 2026WERNER ROBERT F. Chief Accounting OfficerSell$11.42K
Mar 06, 2026Cho Dennis See RemarksSell$19.73K
Mar 06, 2026Green Paula SVP of Human ResourcesSell$43.41K
Mar 06, 2026Leproust Emily M. Chief Executive OfficerSell$112.49K
Feb 23, 2026Finn Patrick John President and COOSell$200.57K

Insider Transactions Trends


DateBuySell
2026 Q1-27
2025 Q4-39
2025 Q3-26
2025 Q2-27
2025 Q1-28

TWST Ownership FAQ


Who Owns Twist Bioscience?

Twist Bioscience shareholders are primarily institutional investors at 86.26%, followed by 1.53% insiders and 12.21% retail investors. The average institutional ownership in Twist Bioscience's industry, Diagnostics & Research Stocks, is 35.25%, which Twist Bioscience exceeds.

Who owns the most shares of Twist Bioscience?

Twist Bioscience’s largest shareholders are Ark investment management (7.56M shares, 12.38%), Artisan partners limited partnership (6.41M shares, 10.69%), and William blair investment management (5.95M shares, 9.75%). Together, they hold 32.81% of Twist Bioscience’s total shares outstanding.

Does Blackrock own Twist Bioscience?

Yes, BlackRock owns 9.33% of Twist Bioscience, totaling 5.42M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 267.28M$. In the last quarter, BlackRock decreased its holdings by -351K shares, a -6.08% change.

Who is Twist Bioscience’s biggest shareholder by percentage of total assets invested?

Tao capital management lp is Twist Bioscience’s biggest shareholder by percentage of total assets invested, with 17.64% of its assets in 828.82K Twist Bioscience shares, valued at 23.32M$.

Who is the top mutual fund holder of Twist Bioscience shares?

ARK Disruptive Innovation Full Composite is the top mutual fund holder of Twist Bioscience shares, with 7.21% of its total shares outstanding invested in 4.42M Twist Bioscience shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools